financetom
Business
financetom
/
Business
/
Semaglutide reduces severity of a type of liver disease in people with HIV, study shows
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Semaglutide reduces severity of a type of liver disease in people with HIV, study shows
Mar 5, 2024 10:20 AM

March 5 (Reuters) - A weekly injection of semaglutide

was safe and reduced the amount of fat in the liver by 31% in

people with HIV and a type of liver disease, a study funded by

the National Institutes of Health showed on Tuesday.

Semaglutide is sold as popular diabetes and weightloss drug

Ozempic and Wegovy by Novo Nordisk.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved